These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23518819)

  • 21. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
    Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained Cardiac Recovery Hinges on Timing and Natural History of Underlying Condition.
    Jaiswal A; Le Jemtel TH; Samson R; Mancini D
    Am J Med Sci; 2018 Jul; 356(1):47-55. PubMed ID: 30049330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic approaches for cardiac regeneration and repair.
    Hashimoto H; Olson EN; Bassel-Duby R
    Nat Rev Cardiol; 2018 Oct; 15(10):585-600. PubMed ID: 29872165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial reverse remodeling: how far can we rewind?
    Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.
    Madonna R; Van Laake LW; Botker HE; Davidson SM; De Caterina R; Engel FB; Eschenhagen T; Fernandez-Aviles F; Hausenloy DJ; Hulot JS; Lecour S; Leor J; Menasché P; Pesce M; Perrino C; Prunier F; Van Linthout S; Ytrehus K; Zimmermann WH; Ferdinandy P; Sluijter JPG
    Cardiovasc Res; 2019 Mar; 115(3):488-500. PubMed ID: 30657875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathophysiology of heart failure.
    Kemp CD; Conte JV
    Cardiovasc Pathol; 2012; 21(5):365-71. PubMed ID: 22227365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
    Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
    Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
    Maybaum S; Mancini D; Xydas S; Starling RC; Aaronson K; Pagani FD; Miller LW; Margulies K; McRee S; Frazier OH; Torre-Amione G;
    Circulation; 2007 May; 115(19):2497-505. PubMed ID: 17485581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell therapy for acute myocardial infarction: on the horizon or still a dream?
    Fish KM; Ishikawa K; Hajjar RJ
    Coron Artery Dis; 2018 Mar; 29(2):89-91. PubMed ID: 29140809
    [No Abstract]   [Full Text] [Related]  

  • 33. Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study.
    Costa MA; Mazzaferri EL; Sievert H; Abraham WT
    Circ Heart Fail; 2014 Sep; 7(5):752-8. PubMed ID: 25037310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle.
    Malliaras KG; Terrovitis JV; Drakos SG; Nanas JN
    J Cardiovasc Transl Res; 2009 Mar; 2(1):114-25. PubMed ID: 20559975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular changes occurring during reverse remodelling following left ventricular assist device support.
    Birks EJ; George RS
    J Cardiovasc Transl Res; 2010 Dec; 3(6):635-42. PubMed ID: 20820974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical unloading and cell therapy have a synergistic role in the recovery and regeneration of the failing heart.
    Ibrahim M; Rao C; Athanasiou T; Yacoub MH; Terracciano CM
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):312-8. PubMed ID: 22378852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study.
    Pokushalov E; Romanov A; Chernyavsky A; Larionov P; Terekhov I; Artyomenko S; Poveshenko O; Kliver E; Shirokova N; Karaskov A; Dib N
    J Cardiovasc Transl Res; 2010 Apr; 3(2):160-8. PubMed ID: 20560030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular assist device-induced molecular changes in the failing myocardium.
    Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
    Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
    Yurista SR; Matsuura TR; Silljé HHW; Nijholt KT; McDaid KS; Shewale SV; Leone TC; Newman JC; Verdin E; van Veldhuisen DJ; de Boer RA; Kelly DP; Westenbrink BD
    Circ Heart Fail; 2021 Jan; 14(1):e007684. PubMed ID: 33356362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
    Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.